Advertisement

No evidence for the effectiveness of systemic corticosteroids in acute pharyngitis, community-acquired pneumonia and acute otitis media

  • N. Principi
  • S. Bianchini
  • E. Baggi
  • S. Esposito
Review

Abstract

Corticosteroids have been used to treat infectious diseases for more than 50 years but, although it has been shown that they are highly effective in improving the clinical course of some diseases, their effects have not been clearly defined in others. Nevertheless, they are still used by a considerable number of physicians. This review analyses the role of systemic corticosteroids in the treatment of acute pharyngitis (AP), community-acquired pneumonia (CAP) and acute otitis media (AOM). A number of trials involving patients with AP have been carried out, but most are marred by methodological flaws that do not allow any firm conclusions to be drawn. The number of trials involving CAP patients is even higher, and the data suggest that corticosteroids may reduce the risk of death only in patients with severe disease. There are very few data concerning AOM, and there is currently no reason for prescribing corticosteroids to treat it. Overall, the data showed that there is, currently, no indication for the universal use of systemic corticosteroids in any of the reviewed diseases and, further, high-quality studies of all of these respiratory tract infections are needed in order to identify the patients for whom the prescription of corticosteroids is rationally acceptable.

Keywords

Respiratory Syncytial Virus Sore Throat Acute Otitis Medium Systemic Corticosteroid Otitis Medium With Effusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

This review was supported, in part, by a grant from the Italian Ministry of Health (Bando Giovani Ricercatori 2009).

Conflict of interest

The authors have no conflict of interest to declare.

References

  1. 1.
    Wisseman CL Jr, Paterson PY, Smadel JE, Diercks FH, Ley HL Jr (1954) Studies on cortisone and antibiotics for prompt therapeutic control of typhoid fever and scrub typhus. J Clin Invest 33:264–275PubMedCrossRefGoogle Scholar
  2. 2.
    Ashby M, Grant H (1955) Tuberculous meningitis treated with cortisone. Lancet 268:65–66PubMedCrossRefGoogle Scholar
  3. 3.
    Breen GE, Talukdar PK (1965) Corticosteroids in the acute infections. Lancet 1:158–160PubMedCrossRefGoogle Scholar
  4. 4.
    McGee S, Hirschmann J (2008) Use of corticosteroids in treating infectious diseases. Arch Intern Med 168:1034–1046PubMedCrossRefGoogle Scholar
  5. 5.
    Barnes PJ (2006) How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 148:245–254PubMedCrossRefGoogle Scholar
  6. 6.
    Esposito S, Picciolli I, Semino M, Principi N (2012) Steroids and childhood encephalitis. Pediatr Infect Dis J 31:759–760PubMedCrossRefGoogle Scholar
  7. 7.
    Shaikh N, Leonard E, Martin JM (2010) Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics 126:e557–e564PubMedCrossRefGoogle Scholar
  8. 8.
    ESCMID Sore Throat Guideline Group, Pelucchi C, Grigoryan L, Galeone C, Esposito S, Huovinen P et al (2012) Guideline for the management of acute sore throat. Clin Microbiol Infect 18(Suppl 1):1–28PubMedCrossRefGoogle Scholar
  9. 9.
    Schappert SM (1998) Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1996. Vital Health Stat 13 134:1–37PubMedGoogle Scholar
  10. 10.
    Ebell MH, Smith MA, Barry HC, Ives K, Carey M (2000) The rational clinical examination. Does this patient have strep throat? JAMA 284:2912–2918PubMedCrossRefGoogle Scholar
  11. 11.
    Esposito S, Bosis S, Begliatti E, Droghetti R, Tremolati E, Tagliabue C et al (2006) Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy. Clin Infect Dis 43:206–209PubMedCrossRefGoogle Scholar
  12. 12.
    Chiappini E, Regoli M, Bonsignori F, Sollai S, Parretti A, Galli L et al (2011) Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther 33:48–58PubMedCrossRefGoogle Scholar
  13. 13.
    Bisno AL (2001) Acute pharyngitis. N Engl J Med 344:205–211PubMedCrossRefGoogle Scholar
  14. 14.
    Mygind N, Nielsen LP, Hoffmann HJ, Shukla A, Blumberga G, Dahl R et al (2001) Mode of action of intranasal corticosteroids. J Allergy Clin Immunol 108(1 Suppl):S16–S25PubMedCrossRefGoogle Scholar
  15. 15.
    Bulloch B, Kabani A, Tenenbein M (2003) Oral dexamethasone for the treatment of pain in children with acute pharyngitis: a randomized, double-blind, placebo-controlled trial. Ann Emerg Med 41:601–608PubMedCrossRefGoogle Scholar
  16. 16.
    Ahn JH, Woo WK, Kim YS, Song YJ, Jeon IK, Jung JR et al (2003) Efficacy of adjuvant short term oral steroid therapy for acute pharyngitis. Korean J Otolaryngol Head Neck Surg 46:971–974Google Scholar
  17. 17.
    Hahn EO, Houser HB, Rammelkamp CH Jr, Denny FW, Wannamaker LW (1951) Effect of cortisone on acute streptococcal infections and poststreptococcal complications. J Clin Invest 30:274–281PubMedCrossRefGoogle Scholar
  18. 18.
    Niland ML, Bonsu BK, Nuss KE, Goodman DG (2006) A pilot study of 1 versus 3 days of dexamethasone as add-on therapy in children with streptococcal pharyngitis. Pediatr Infect Dis J 25:477–481PubMedCrossRefGoogle Scholar
  19. 19.
    Wei JL, Kasperbauer JL, Weaver AL, Boggust AJ (2002) Efficacy of single-dose dexamethasone as adjuvant therapy for acute pharyngitis. Laryngoscope 112:87–93PubMedCrossRefGoogle Scholar
  20. 20.
    Kiderman A, Yaphe J, Bregman J, Zemel T, Furst AL (2005) Adjuvant prednisone therapy in pharyngitis: a randomised controlled trial from general practice. Br J Gen Pract 55:218–221PubMedGoogle Scholar
  21. 21.
    Olympia RP, Khine H, Avner JR (2005) Effectiveness of oral dexamethasone in the treatment of moderate to severe pharyngitis in children. Arch Pediatr Adolesc Med 159:278–282PubMedCrossRefGoogle Scholar
  22. 22.
    O’Brien JF, Meade JL, Falk JL (1993) Dexamethasone as adjuvant therapy for severe acute pharyngitis. Ann Emerg Med 22:212–215PubMedCrossRefGoogle Scholar
  23. 23.
    Marvez-Valls EG, Ernst AA, Gray J, Johnson WD (1998) The role of betamethasone in the treatment of acute exudative pharyngitis. Acad Emerg Med 5:567–572PubMedCrossRefGoogle Scholar
  24. 24.
    Tasar A, Yanturali S, Topacoglu H, Ersoy G, Unverir P, Sarikaya S (2008) Clinical efficacy of dexamethasone for acute exudative pharyngitis. J Emerg Med 35:363–367PubMedCrossRefGoogle Scholar
  25. 25.
    Hayward G, Thompson M, Heneghan C, Perera R, Del Mar C, Glasziou P (2009) Corticosteroids for pain relief in sore throat: systematic review and meta-analysis. BMJ 339:b2976. doi: 10.1136/bmj.b2976 PubMedCrossRefGoogle Scholar
  26. 26.
    Wing A, Villa-Roel C, Yeh B, Eskin B, Buckingham J, Rowe BH (2010) Effectiveness of corticosteroid treatment in acute pharyngitis: a systematic review of the literature. Acad Emerg Med 17:476–483PubMedCrossRefGoogle Scholar
  27. 27.
    Korb K, Scherer M, Chenot JF (2010) Steroids as adjuvant therapy for acute pharyngitis in ambulatory patients: a systematic review. Ann Fam Med 8:58–63PubMedCrossRefGoogle Scholar
  28. 28.
    Tagliabue C, Techasaensiri C, Torres JP, Katz K, Meek C, Kannan TR et al (2011) Efficacy of increasing dosages of clarithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia. J Antimicrob Chemother 66:2323–2329PubMedCrossRefGoogle Scholar
  29. 29.
    Garcia-Vidal C, Carratalà J, Fernández-Sabé N, Dorca J, Verdaguer R, Manresa F et al (2009) Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect 15:1033–1038PubMedCrossRefGoogle Scholar
  30. 30.
    Chiappini E, Principi N, Mansi N, Serra A, De Masi S, Camaioni A et al (2012) Management of acute pharyngitis in children: summary of the Italian National Institute of Health guidelines. Clin Ther 34:1442–1458.e2PubMedCrossRefGoogle Scholar
  31. 31.
    Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH; Infectious Diseases Society of America (2002) Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 35:113–125PubMedCrossRefGoogle Scholar
  32. 32.
    Fine AM, Nizet V, Mandl KD (2012) Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch Intern Med 172:847–852PubMedCrossRefGoogle Scholar
  33. 33.
    Giraldez-Garcia C, Rubio B, Gallegos-Braun JF, Imaz I, Gonzalez-Enriquez J, Sarria-Santamera A (2011) Diagnosis and management of acute pharyngitis in a paediatric population: a cost-effectiveness analysis. Eur J Pediatr 170:1059–1067PubMedCrossRefGoogle Scholar
  34. 34.
    Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR (2007) Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 369:1179–1186PubMedCrossRefGoogle Scholar
  35. 35.
    Ruhnke GW, Coca-Perraillon M, Kitch BT, Cutler DM (2010) Trends in mortality and medical spending in patients hospitalized for community-acquired pneumonia: 1993–2005. Med Care 48:1111–1116PubMedCrossRefGoogle Scholar
  36. 36.
    Peck AJ, Holman RC, Curns AT, Lingappa JR, Cheek JE, Singleton RJ et al (2005) Lower respiratory tract infections among American Indian and Alaska Native children and the general population of U.S. children. Pediatr Infect Dis J 24:342–351PubMedCrossRefGoogle Scholar
  37. 37.
    Thomas CP, Ryan M, Chapman JD, Stason WB, Tompkins CP, Suaya JA et al. (2012) Incidence and cost of pneumonia in medicare beneficiaries. Chest. Epub Mar 8Google Scholar
  38. 38.
    Sibille Y, Reynolds HY (1990) Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141:471–501PubMedGoogle Scholar
  39. 39.
    Mizgerd JP (2008) Acute lower respiratory tract infection. N Engl J Med 358:716–727PubMedCrossRefGoogle Scholar
  40. 40.
    Cazzola M, Matera MG, Pezzuto G (2005) Inflammation—a new therapeutic target in pneumonia. Respiration 72:117–126PubMedCrossRefGoogle Scholar
  41. 41.
    Wagner HN Jr, Bennett IL Jr, Lasagna L, Cluff LE, Rosenthal MB, Mirick GS (1956) The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin. Bull Johns Hopkins Hosp 98:e197–e215Google Scholar
  42. 42.
    Chen Y, Li K, Pu H, Wu T (2011) Corticosteroids for pneumonia. Cochrane Database Syst Rev 3:CD007720PubMedGoogle Scholar
  43. 43.
    McHardy VU, Schonell ME (1972) Ampicillin dosage and use of prednisolone in treatment of pneumonia: co-operative controlled trial. Br Med J 4(5840):569–573PubMedCrossRefGoogle Scholar
  44. 44.
    van Woensel JB, Vyas H; STAR Trial Group (2011) Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial. Crit Care Med 39:1779–1783PubMedCrossRefGoogle Scholar
  45. 45.
    Marik P, Kraus P, Sribante J, Havlik I, Lipman J, Johnson DW (1993) Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study. Chest 104:389–392PubMedCrossRefGoogle Scholar
  46. 46.
    Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G et al (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171:242–248PubMedCrossRefGoogle Scholar
  47. 47.
    Mikami K, Suzuki M, Kitagawa H, Kawakami M, Hirota N, Yamaguchi H et al (2007) Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung 185:249–255PubMedCrossRefGoogle Scholar
  48. 48.
    Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG (2010) Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med 181:975–982PubMedCrossRefGoogle Scholar
  49. 49.
    Fernández-Serrano S, Dorca J, Garcia-Vidal C, Fernández-Sabé N, Carratalà J, Fernández-Agüera A et al (2011) Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care 15:R96PubMedCrossRefGoogle Scholar
  50. 50.
    Meijvis SC, Hardeman H, Remmelts HH, Heijligenberg R, Rijkers GT, van Velzen-Blad H et al (2011) Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet 377:2023–2030PubMedCrossRefGoogle Scholar
  51. 51.
    Remmelts HH, Meijvis SC, Heijligenberg R, Rijkers GT, Oosterheert JJ, Bos WJ et al. (2012) Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia. J Infect 65:25–31PubMedCrossRefGoogle Scholar
  52. 52.
    Tamura A, Matsubara K, Tanaka T, Nigami H, Yura K, Fukaya T (2008) Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect 57:223–228PubMedCrossRefGoogle Scholar
  53. 53.
    Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D et al (2006) Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 41:263–268PubMedCrossRefGoogle Scholar
  54. 54.
    Weiss AK, Hall M, Lee GE, Kronman MP, Sheffler-Collins S, Shah SS (2011) Adjunct corticosteroids in children hospitalized with community-acquired pneumonia. Pediatrics 127:e255–e263PubMedCrossRefGoogle Scholar
  55. 55.
    Pugh RJ, Roy N. Systemic corticosteroids in community acquired pneumonia in adults: a systematic review and meta-analysis. Available online at: http://cdn.f1000.com/posters/docs/211027821. Accessed on 30 Jun 2012
  56. 56.
    Zorc JJ, Hall CB (2010) Bronchiolitis: recent evidence on diagnosis and management. Pediatrics 125:342–349PubMedCrossRefGoogle Scholar
  57. 57.
    Principi N, Baggi E, Esposito S (2012) Prevention of acute otitis media using currently available vaccines. Future Microbiol 7:457–465PubMedCrossRefGoogle Scholar
  58. 58.
    Coker TR, Chan LS, Newberry SJ, Limbos MA, Suttorp MJ, Shekelle PG et al (2010) Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA 304:2161–2169PubMedCrossRefGoogle Scholar
  59. 59.
    Chonmaitree T, Patel JA, Lett-Brown MA, Uchida T, Garofalo R, Owen MJ et al (1994) Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media. J Infect Dis 169:1265–1270PubMedCrossRefGoogle Scholar
  60. 60.
    Chonmaitree T, Patel JA, Sim T, Garofalo R, Uchida T, Sim T, et al (1996) Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media. Ann Otol Rhinol Laryngol 105:968–974PubMedGoogle Scholar
  61. 61.
    Hamaguchi Y, Juhn SK, Sakakura Y (1988) Antiinflammatory effects of a corticosteroid and protease inhibitor agents on antigen-induced otitis media in chinchillas. Am J Otolaryngol 9:142–148PubMedCrossRefGoogle Scholar
  62. 62.
    Chonmaitree T, Saeed K, Uchida T, Heikkinen T, Baldwin CD, Freeman DH Jr et al (2003) A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media. J Pediatr 143:377–385PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • N. Principi
    • 1
  • S. Bianchini
    • 1
  • E. Baggi
    • 1
  • S. Esposito
    • 1
  1. 1.Pediatric Clinic 1, Department of Pathophysiology and TransplantationUniversità degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Mangiagalli e Regina ElenaMilanoItaly

Personalised recommendations